MALrisk: a machne-learning based tool to predict imported malaria in returned travellers with fever.
Balerdi-Sarasola L., Pedro F., Bottieau E., Genton B., Petrone P., Muñoz J., Camprubí-Ferrer D. Journal of travel medicine. Peer-reviewed.
MALrisk: a machne-learning based tool to predict imported malaria in returned travellers with fever.
Balerdi-Sarasola L., Pedro F., Bottieau E., Genton B., Petrone P., Muñoz J., Camprubí-Ferrer D. Journal of travel medicine. Peer-reviewed.
Assessing viral metagenomics for the diagnosis of acute undifferentiated fever in returned travellers: a multicenter cohort study.
Camprubí-Ferrer D., Tomazatos A., Balerdi-Sarasola L., Cobuccio L.G., Van Den Broucke S., Horváth B., Van Esbroeck M., Martinez M.J., Gandasegui J., Subirà C. et al., 2024/04/06. Journal of travel medicine, 31 (3). Peer-reviewed.
Assessing viral metagenomics for the diagnosis of acute undifferentiated fever in returned travellers: a multicenter cohort study.
Camprubí-Ferrer D., Tomazatos A., Balerdi-Sarasola L., Cobuccio L.G., Van Den Broucke S., Horváth B., Van Esbroeck M., Martinez M.J., Gandasegui J., Subirà C. et al., 2024/04/06. Journal of travel medicine, 31 (3). Peer-reviewed.
Injuries and medical emergencies among international travellers.
Potin M., Carron P.N., Genton B., 2024/01/28. Journal of travel medicine, 31 (1). Peer-reviewed.
Injuries and medical emergencies among international travellers.
Potin M., Carron P.N., Genton B., 2024/01/28. Journal of travel medicine, 31 (1). Peer-reviewed.
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Miauton A., Audran R., Besson J., Maby-El Hajjami H., Karlen M., Warpelin-Decrausaz L., Sene L., Schaufelberger S., Faivre V., Faouzi M. et al., 2024/01. EBioMedicine, 99 p. 104922. Peer-reviewed.
Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study.
Miauton A., Audran R., Besson J., Maby-El Hajjami H., Karlen M., Warpelin-Decrausaz L., Sene L., Schaufelberger S., Faivre V., Faouzi M. et al., 2024/01. EBioMedicine, 99 p. 104922. Peer-reviewed.
R21/Matrix-M™ malaria vaccine: a new tool to achieve WHO's goal to eliminate malaria in 30 countries by 2030?
Genton B., 2023/12/28. Journal of travel medicine, 30 (8) pp. taad140. Peer-reviewed.
R21/Matrix-M™ malaria vaccine: a new tool to achieve WHO's goal to eliminate malaria in 30 countries by 2030?
Genton B., 2023/12/28. Journal of travel medicine, 30 (8) pp. taad140. Peer-reviewed.
Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study.
Camprubí-Ferrer D., Cobuccio L., Van Den Broucke S., Balerdi-Sarasola L., Genton B., Bottieau E., Navero-Castillejos J., Martinez M.J., Jay C., Grange A. et al., 2023/05/18. Journal of travel medicine, 30 (3) pp. taad041. Peer-reviewed.
Clinical evaluation of BioFire® multiplex-PCR panel for acute undifferentiated febrile illnesses in travellers: a prospective multicentre study.
Camprubí-Ferrer D., Cobuccio L., Van Den Broucke S., Balerdi-Sarasola L., Genton B., Bottieau E., Navero-Castillejos J., Martinez M.J., Jay C., Grange A. et al., 2023/05/18. Journal of travel medicine, 30 (3) pp. taad041. Peer-reviewed.
Doxycycline responding illnesses in returning travellers with undifferentiated non-malaria fever: a European multicentre prospective cohort study.
Camprubí-Ferrer D., Oteo J.A., Bottieau E., Genton B., Balerdi-Sarasola L., Portillo A., Cobuccio L., Van Den Broucke S., Santibáñez S., Cadar D. et al., 2023/02/18. Journal of travel medicine, 30 (1) pp. taac094. Peer-reviewed.
Doxycycline responding illnesses in returning travellers with undifferentiated non-malaria fever: a European multicentre prospective cohort study.
Camprubí-Ferrer D., Oteo J.A., Bottieau E., Genton B., Balerdi-Sarasola L., Portillo A., Cobuccio L., Van Den Broucke S., Santibáñez S., Cadar D. et al., 2023/02/18. Journal of travel medicine, 30 (1) pp. taac094. Peer-reviewed.
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Cobuccio L.G., Laurent M., Gardiol C., Wampfler R., Poppert S., Senn N., Eperon G., Genton B., Locatelli I., de Vallière S., 2023/02/18. Journal of travel medicine, 30 (1) pp. taac143. Peer-reviewed.
Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial.
Cobuccio L.G., Laurent M., Gardiol C., Wampfler R., Poppert S., Senn N., Eperon G., Genton B., Locatelli I., de Vallière S., 2023/02/18. Journal of travel medicine, 30 (1) pp. taac143. Peer-reviewed.
Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial.
Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Gouveia A., Jaton K., Opota O., Maillard A., Minghelli G. et al., 2023. PloS one, 18 (2) pp. e0282150. Peer-reviewed.
Antigen rapid tests, nasopharyngeal PCR and saliva PCR to detect SARS-CoV-2: A prospective comparative clinical trial.
Schwob J.M., Miauton A., Petrovic D., Perdrix J., Senn N., Gouveia A., Jaton K., Opota O., Maillard A., Minghelli G. et al., 2023. PloS one, 18 (2) pp. e0282150. Peer-reviewed.
Crise du Covid-19 : le testing et la vaccination à l’aune des rendements décroissants [Covid-19 crisis: testing and vaccination in the light of diminishing returns]
D'acremont V., Chambaz G., Genton B., 2022/05/04. Revue medicale suisse, 18 (780) pp. 904-908. Peer-reviewed.
Crise du Covid-19 : le testing et la vaccination à l’aune des rendements décroissants [Covid-19 crisis: testing and vaccination in the light of diminishing returns]
D'acremont V., Chambaz G., Genton B., 2022/05/04. Revue medicale suisse, 18 (780) pp. 904-908. Peer-reviewed.